MedTrace Logo

Hyperglycemia in Patients with Stroke and Indication of Enteral Nutrition

NCT03422900 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of a specific nutritional formula for diabetics on the development of hyperglycemia in patients with recent non-diabetic stroke who require admission and enteral nutritional support by nasogastric tube. As well as the effect on metabolic control, development of comorbidities, hospital stay, readmissions, mortality and tolerance of the formula under study.

Conditions

  • Hyperglycaemia (Non Diabetic)
  • Enteral Feeding Intolerance
  • Stroke

Interventions

DIETARY_SUPPLEMENT

Diabetes-Specific enteral formula

Complete enteral formula normocaloric hyperproteic with fiber (80% SOLUBLE)

DIETARY_SUPPLEMENT

Standard formula

Complete enteral formula normocaloric hormoproteic without fiber

Sponsors & Collaborators

  • Endocrinology and Clinical Nutrition Research Center, Spain

    lead OTHER

Principal Investigators

  • Daniel A De Luis Román, Prof. Dr. · Service of Endocrinology and Nutrition. Clinic Hospital University of Valladolid

  • Juan J López-Gómez, Prof. Dr. · Service of Endocrinology and Nutrition. Clinic Hospital University of Valladolid

  • Javier F Arenillas-Lara, Prof. Dr. · Service of Neurology. Clinic Hospital University of Valladolid

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-12
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03422900 on ClinicalTrials.gov